Top Markets
Coin of the day
Zynerba Pharmaceuticals, Inc. Zynerba Pharmaceuticals, Inc.

Zynerba Pharmaceuticals, Inc.

ZYNE
Classificação em ações #26763
Zynerba Pharmaceuticals, Inc. is a specialized pharmaceutical firm currently in... Zynerba Pharmaceuticals, Inc. is a specialized pharmaceutical firm currently in the clinical development phase. Its primary objective is to create and advance medicinal transdermal cannabinoid treatments specifically for uncommon and scarcely encountered neuropsychiatric conditions. A key product in its pipeline is Zygel, a pharmaceutical-grade cannabidiol expertly crafted into a gel with enhanced skin penetration for topical application. Originally established as AllTranz, Inc., the company adopted its current name, Zynerba Pharmaceuticals, Inc., in August 2014. Founded in 2007, Zynerba Pharmaceuticals maintains its headquarters in Devon, Pennsylvania.
Preço da ação
$1.30
Última sincronização: 2023-10-13
Valor de mercado
$38.02M
Variação (1 dia)
0.00%
Variação (1 ano)
0.00%
País
US
Negociar Zynerba Pharmaceuticals, Inc. (ZYNE)

Categoria

Histórico de rendimento de dividendos para Zynerba Pharmaceuticals, Inc. (ZYNE)
O rendimento de dividendos (TTM) da Zynerba Pharmaceuticals, Inc. (símbolo da ação: ZYNE) em 2026 é: 0
Rendimento médio dos dividendos nos últimos 5 anos: 0.00%
Histórico de rendimento de dividendos para Zynerba Pharmaceuticals, Inc. (ZYNE) de 2026 a 2026
Rendimento de dividendos no final de cada ano (TTM)
Ano Rendimento de Dividendos Alterar
Não há dados suficientes para as datas fornecidas.
Rendimentos de dividendos (TTM) para empresas semelhantes ou concorrentes